IP Library › Assignment 053997/0501
Patent Assignment
Reel/Frame 053997/0501

Assignment of Assignor's Interest

Recorded: 2020-10-07 Pages: 6
Assignors
SOMMADOSSI, JEAN-PIERRE
Executed: 2016-03-04
MOUSSA, ADEL
Executed: 2016-03-04
Assignee
ATEA PHARMACEUTICALS, INC.
125 SUMMER STREET, BOSTON, MASSACHUSETTS, 02110
Covered Properties (3)
Beta-D-2'-Deoxy-2'-Alpha-Fluoro-2'-Beta-C-Substituted-2-Modified-N6-Substituted Purine Nucleotides for Hcv Treatment
Application: 16/918,898 →
Publication: US 2020/0331955
Beta-D-2'-Deoxy-2'-Alpha-Fluoro-2'-Beta-C-Substituted-2-Modified-N6-Substituted Purine Nucleotides for Hcv Treatment
Application: 16/918,914 →
Publication: US 2020/0331956
Beta-D-2'-DEOXY-2'-Alpha-FLUORO-2'-Beta-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
Application: 17/028,724 →
Publication: US 2021/0009628
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 16, 2020
From: SOMMADOSSI, JEAN-PIERRE; MOUSSA, ADEL
To: ATEA PHARMACEUTICALS, INC.
Reel/Frame 054369/0895 →
Corrective Assignment to Correct the Application Number 17028319 Previously Recorded at Reel: 053997 Frame: 0501. Assignor(S) Hereby Confirms the Assignment. Nov 28, 2022
From: SOMMADOSSI, JEAN-PIERRE; MOUSSA, ADEL
To: ATEA PHARMACEUTICALS, INC.
Reel/Frame 062003/0409 →